Skip to content
Trial Eligibility
Menu

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

NCT05522972

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Amblyopia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Accepted
Sponsor
Nova Southeastern University
Last updated on ClinicalTrials.gov
December 16, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Nova Southeastern University College of Optometry · Fort Lauderdale, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.